Gain insights into RxSight's Q1 2025 earnings highlights, revised guidance, market challenges, and growth strategies.

NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients ...

RxSight (RXST) stock plunged 28% as the MedTech firm cut full-year guidance and issued disappointing early Q1 results, citing ...

Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...

Phakic IOL technologies have undergone substantial improvements in recent years, with progressive upgrades in design and material and more accurate sizing strategies.At the ESCRS winter meeting, Erik ...

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...

The May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a ...

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 ...

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...